股本结构
单位：万股
| 公告日期 | 2024-03-14 | 2023-11-09 | 2023-08-10 | 2023-08-10 | 2023-05-11 | 2023-03-16 |
|---|---|---|---|---|---|---|
| 证券总股本 | 2568.81 | 2565.84 | 2565.34 | 2556.20 | 2550.44 | 2545.81 |
| 普通股本 | 2568.81 | 2565.84 | 2565.34 | 2556.20 | 2550.44 | 2545.81 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2023-12-31 | 2023-09-30 | 2023-08-04 | 2023-06-30 | 2023-03-31 | 2023-03-07 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-03-14 | 2568.81 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Employee stock purchase plan
Stock option exercises and vesting of restricted stock units
Shares withheld related to net share settlement of stock option exercises
|
2023-12-31 |
| 2023-11-09 | 2565.84 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Stock option exercises and vesting of restricted stock units
|
2023-09-30 |
| 2023-08-10 | 2565.34 | 未披露 | 定期报告 | 2023-08-04 |
| 2023-08-10 | 2556.20 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Employee stock purchase plan
|
2023-06-30 |
| 2023-05-11 | 2550.44 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Shares withheld related to net share settlement of stock option exercises
Stock option exercises
|
2023-03-31 |
| 2023-03-16 | 2545.81 | 未披露 | 定期报告 | 2023-03-07 |
| 2023-03-16 | 2535.31 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Stock option exercises
Stock warrant exercises
Employee stock purchase plan
|
2022-12-31 |
| 2022-11-10 | 2529.70 | 未披露 |
更多>>
From June 30, 2022 to August 8, 2022
Stock option exercises
|
2022-08-08 |
| 2022-08-11 | 2527.20 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Employee stock purchase plan
Warrant exercises
|
2022-06-30 |
| 2022-05-12 | 2522.45 | 未披露 | 定期报告 | 2022-04-30 |
| 2022-03-16 | 2462.60 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Stock option exercises
Employee stock purchase plan
Common stock issued related to restricted stock units
Stock warrant exercises
|
2021-12-31 |
| 2021-11-16 | 2460.62 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Stock option exercises
|
2021-09-30 |
| 2021-08-16 | 2460.02 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Stock option exercises
Employee stock purchase plan
Common stock issued related to restricted stock units
|
2021-06-30 |
| 2021-05-13 | 2450.76 | 未披露 | 定期报告 | 2021-04-30 |
| 2021-04-12 | 2451.08 | 未披露 |
更多>>
1.Common stock offered by selling stockholder 1,518,000 shares，including 198,000 shares of Common Stock issued pursuant to the full exercise by the underwriter, National Securities Corporation, of its over-allotment option.
2.The number of shares of common stock that will be issued and outstanding immediately before this offering is based on 24,312,808 shares of common stock issued and outstanding as of December 31, 2020.
|
2021-04-12 |
| 2021-05-13 | 2448.26 | 未披露 |
更多>>
From December 31, 2020 To March 31, 2021
Stock option exercises
Warrant exercises
|
2021-03-31 |
| 2021-03-16 | 2440.76 | 未披露 | 定期报告 | 2021-03-08 |
| 2021-03-16 | 2431.28 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Stock-based compensation
Stock option exercises
Employee stock purchase plan
Proceeds from sales of common stock, net of offering costs
Issuance of common stock for product candidate licensing rights
|
2020-12-31 |
| 2020-11-12 | 2421.35 | 未披露 | 定期报告 | 2020-11-02 |
| 2020-10-16 | 2375.60 | 未披露 |
更多>>
1.Common stock offered by the company 2,800,000 shares.
2.The number of shares of common stock that will be issued and outstanding immediately after this offering is based on 20,956,033 shares of common stock issued and outstanding as of June 30, 2020.
|
2020-10-16 |
| 2020-11-12 | 2098.85 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Stock option exercises
|
2020-09-30 |
| 2020-08-12 | 2095.60 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Stock option exercises
Employee stock purchase plan
Stock warrant exercises
|
2020-06-30 |
| 2020-05-14 | 2091.70 | 未披露 | 定期报告 | 2020-04-30 |
| 2020-04-22 | 2090.18 | 未披露 | 定期报告 | 2020-04-15 |
| 2020-05-14 | 2076.20 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Stock option exercises
Proceeds from sales of common stock, net of offering costs
Issuance of common stock for product candidate licensing rights
|
2020-03-31 |
| 2020-03-30 | 1988.25 | 未披露 | 定期报告 | 2020-03-26 |
| 2020-03-05 | 1788.25 | 未披露 | 定期报告 | 2020-02-28 |
| 2020-03-05 | 1787.75 | 未披露 |
更多>>
from December 31, 2018 to December 31, 2019
Stock option exercises
Common stock issued under employee stock purchase plan
Stock warrant exercises
|
2019-12-31 |
| 2019-11-14 | 1780.72 | 未披露 |
更多>>
From June 30, 2019 to September 30, 2019
Stock option exercises
|
2019-09-30 |
| 2019-08-06 | 1776.30 | 未披露 |
更多>>
from March 31, 2019 to June 30,2019
Stock option exercises
Employee stock purchase plan
Stock warrant exercises
|
2019-06-30 |
| 2019-05-07 | 1762.79 | 未披露 |
更多>>
from December 31, 2018 to March 15, 2019
Stock option exercises
|
2019-03-15 |
| 2019-03-25 | 1760.79 | 未披露 |
更多>>
from December 31, 2017 to December 14, 2018
Stock-based compensation
Issuance of common stock in connection with initial public offering, including underwriter’s over-allotment, net of offering costs and underwriter’s discount
Conversion of redeemable convertible preferred stock (including accrued dividends) to common stock in connection with initial public offering
|
2018-12-14 |
| 2018-11-13 | 1691.84 | 未披露 |
更多>>
1.Common stock offered 3,600,000 shares
2.The number of shares of our common stock to be outstanding after this offering is based on 13,318,354 shares of common stock outstanding as of the date of this prospectus (including preferred stock on an as-converted basis as of June 30, 2018 assuming a conversion price of $3.00 per share of the Series A preferred stock)
|
2018-11-13 |
| 2018-12-20 | 621.90 | 668.51 |
更多>>
From December 31, 2017 to September 30, 2018
Stock-based compensation
|
2018-09-30 |
| 2018-08-10 | 1321.73 | 未披露 | 定期报告 | 2018-08-10 |
| 2018-09-25 | 1331.84 | 未披露 | 定期报告 | 2018-06-30 |
From December 31, 2022 to December 31, 2023
Employee stock purchase plan
Stock option exercises and vesting of restricted stock units
Shares withheld related to net share settlement of stock option exercises
From June 30, 2023 to September 30, 2023
Stock option exercises and vesting of restricted stock units
From March 31, 2023 to June 30, 2023
Employee stock purchase plan
From December 31, 2022 to March 31, 2023
Shares withheld related to net share settlement of stock option exercises
Stock option exercises
From December 31, 2021 to December 31, 2022
Stock option exercises
Stock warrant exercises
Employee stock purchase plan
From June 30, 2022 to August 8, 2022
Stock option exercises
From March 31, 2022 to June 30, 2022
Employee stock purchase plan
Warrant exercises
From December 31, 2020 to December 31, 2021
Stock option exercises
Employee stock purchase plan
Common stock issued related to restricted stock units
Stock warrant exercises
From June 30, 2021 to September 30, 2021
Stock option exercises
From March 31, 2021 to June 30, 2021
Stock option exercises
Employee stock purchase plan
Common stock issued related to restricted stock units
1.Common stock offered by selling stockholder 1,518,000 shares，including 198,000 shares of Common Stock issued pursuant to the full exercise by the underwriter, National Securities Corporation, of its over-allotment option.
2.The number of shares of common stock that will be issued and outstanding immediately before this offering is based on 24,312,808 shares of common stock issued and outstanding as of December 31, 2020.
From December 31, 2020 To March 31, 2021
Stock option exercises
Warrant exercises
From December 31, 2019 to December 31, 2020
Stock-based compensation
Stock option exercises
Employee stock purchase plan
Proceeds from sales of common stock, net of offering costs
Issuance of common stock for product candidate licensing rights
1.Common stock offered by the company 2,800,000 shares.
2.The number of shares of common stock that will be issued and outstanding immediately after this offering is based on 20,956,033 shares of common stock issued and outstanding as of June 30, 2020.
From June 30, 2020 to September 30, 2020
Stock option exercises
From March 31, 2020 to June 30, 2020
Stock option exercises
Employee stock purchase plan
Stock warrant exercises
From December 31, 2019 to March 31, 2020
Stock option exercises
Proceeds from sales of common stock, net of offering costs
Issuance of common stock for product candidate licensing rights
from December 31, 2018 to December 31, 2019
Stock option exercises
Common stock issued under employee stock purchase plan
Stock warrant exercises
From June 30, 2019 to September 30, 2019
Stock option exercises
from March 31, 2019 to June 30,2019
Stock option exercises
Employee stock purchase plan
Stock warrant exercises
from December 31, 2018 to March 15, 2019
Stock option exercises
from December 31, 2017 to December 14, 2018
Stock-based compensation
Issuance of common stock in connection with initial public offering, including underwriter’s over-allotment, net of offering costs and underwriter’s discount
Conversion of redeemable convertible preferred stock (including accrued dividends) to common stock in connection with initial public offering
1.Common stock offered 3,600,000 shares
2.The number of shares of our common stock to be outstanding after this offering is based on 13,318,354 shares of common stock outstanding as of the date of this prospectus (including preferred stock on an as-converted basis as of June 30, 2018 assuming a conversion price of $3.00 per share of the Series A preferred stock)
From December 31, 2017 to September 30, 2018
Stock-based compensation